Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists

Abstract

Patients with inflammatory arthritis who are undergoing treatment with infliximab appear to be at higher risk for developing symptomatic coccidioidomycosis as compared with those not receiving infliximab.